Monthly Archives: April 2008

Side Effects: Merck is not the first pharmaceutical company to use ghost-writers

Share An article in The New York Times a few days ago about Vioxx almost makes it sound as if the ghostwriting of new drug studies by pharmaceutical companies is a new and relatively unknown practice. In fact, the ghost-writing … Continue reading

Posted in Uncategorized | 3 Comments